American Lithium Corp. (CVE:LI – Get Free Report) Director Claudia Tornquist sold 30,000 shares of the firm’s stock in a transaction that occurred on Monday, September 23rd. The shares were sold at an average price of C$0.50, for a total value of C$15,000.00.
Claudia Tornquist also recently made the following trade(s):
- On Friday, September 20th, Claudia Tornquist sold 30,000 shares of American Lithium stock. The shares were sold at an average price of C$0.50, for a total value of C$15,000.00.
American Lithium Trading Up 1.8 %
American Lithium stock opened at C$0.56 on Wednesday. American Lithium Corp. has a 12 month low of C$0.44 and a 12 month high of C$1.99. The company has a quick ratio of 1.45, a current ratio of 5.35 and a debt-to-equity ratio of 0.07. The business has a 50 day moving average price of C$0.57 and a two-hundred day moving average price of C$0.77. The stock has a market cap of C$121.83 million, a price-to-earnings ratio of -3.29 and a beta of 2.22.
Analyst Ratings Changes
A number of brokerages recently issued reports on LI. National Bank Financial upgraded American Lithium to a “strong-buy” rating in a report on Thursday, June 6th. National Bankshares set a C$1.50 target price on American Lithium and gave the stock an “outperform” rating in a research report on Thursday, June 6th.
Check Out Our Latest Analysis on American Lithium
About American Lithium
American Lithium Corp., an exploration and development stage company, engages in the acquisition, exploration, and development of resource properties in the United States. It principally focuses on the TLC Lithium Project located in the town of Tonopah, Nevada; and the Falchani Lithium project and the Macusani Uranium project located in Puno, Peru.
See Also
- Five stocks we like better than American Lithium
- Industrial Products Stocks Investing
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Best Stocks Under $5.00
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Best Stocks Under $10.00
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for American Lithium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Lithium and related companies with MarketBeat.com's FREE daily email newsletter.